• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, Jan. 25 Neuland Laboratories Ltd (NLL) has more than doubled its net profit for the third quarter ended December 31, 2007 at Rs 3.5 crore (Rs 1.69 crore).

The Hyderabad-based, Active Pharmaceutical Ingredients (API) maker reported a turnover of Rs 57.88 crore (Rs 49.67 crore) during the quarter under review, a growth of 18.69 per cent over the corresponding quarter last year. The earnings per share (EPS) was Rs 6.5 (Rs 3.13).

Dr D.R. Rao, Chairman & Managing Director, Neuland Laboratories, said “Continuing with our focused plans of being profitable and giving more value to our investors, besides growing our client base the company has always had strong business growth initiatives”.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Magma Shrachi Fin Q3 net up

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line